Silo Wellness Inc. (SILFF) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Silo Wellness Inc. (SILFF) trades at $0.0112. Silo Wellness Inc. is a psychedelics and wellness company focused on developing psychedelic medicine to reduce trauma. Market cap: $1.73M, Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for SILFF: SILFF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates SILFF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
Not enough scored data yet to form a council read on SILFF.
How is this calculated? →Silo Wellness Inc. (SILFF) Healthcare & Pipeline Overview
Silo Wellness Inc. is a psychedelics and wellness company developing psychedelic medicine and functional mushroom products. It offers Jamaican and Oregon psychedelic wellness retreats and cultivates psychedelic mushrooms and truffles in Jamaica, positioning itself in the burgeoning psychedelic wellness market with a focus on trauma reduction.
What Is the Investment Thesis for SILFF?
Silo Wellness Inc. operates in the high-growth potential psychedelic wellness market. The company's focus on developing psychedelic medicine and functional mushroom products positions it to capitalize on the increasing acceptance and legalization of psychedelics for therapeutic purposes. Key value drivers include the successful development and commercialization of its psilocybin nasal spray, expansion of its wellness retreat offerings, and the establishment of a strong retail presence in Jamaica. However, the company faces significant risks, including regulatory hurdles, competition from other players in the market, and the need for substantial capital investment to fund its growth initiatives. With a negative P/E ratio of -0.09 and a negative profit margin of -1730.9%, the company's financial performance requires close monitoring. The gross margin of 36.6% indicates potential for profitability as the company scales its operations.
Based on FMP financials and quantitative analysis
SILFF Key Highlights
Market Cap of $1.73M reflects the company's early stage and potential for growth in the emerging psychedelic wellness market.
- P/E Ratio of -0.09 indicates the company is currently not profitable, typical for growth-stage companies in the biotech sector.
- Profit Margin of -1730.9% highlights the significant investments being made in research and development and market expansion.
- Gross Margin of 36.6% suggests potential for profitability as the company scales its operations and optimizes its cost structure.
- Beta of 0.77 indicates lower volatility compared to the overall market, which may appeal to risk-averse investors.
Who Are SILFF's Competitors?
SILFF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| INNPF INNOCAN PHARMA Corp | $1.60 | -8.05% | $7.20M | 61 |
| GENH Generation Hemp, Inc. | $0.22 | +0.00% | $25.3M | 63 |
| GBLP Global Pharmatech, Inc. | $0.08 | +0.00% | $33.3M | 62 |
| ETST Earth Science Tech, Inc. | $0.12 | +14.45% | $35.3M | 61 |
| GDNSF Goodness Growth Holdings, Inc. | $0.45 | +0.00% | $61.1M | 64 |
| MNNGF Baijin Life Science Holdings Limited | $0.08 | +0.00% | $74.6M | 63 |
| SHIEF Shield Therapeutics plc | $0.07 | +0.00% | $75.3M | 62 |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109M | 66 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SILFF's Key Strengths?
First-mover advantage in the emerging psychedelic wellness market.
- Vertically integrated supply chain for psychedelic mushrooms and truffles.
- Unique wellness retreat offerings in Jamaica and Oregon.
- Proprietary formulation of psilocybin nasal spray.
What Are SILFF's Weaknesses?
Limited operating history and financial resources.
- Dependence on regulatory approvals for psilocybin-based products.
- High level of competition in the wellness market.
- Negative profit margin and limited revenue streams.
What Could Drive SILFF Stock Higher?
Regulatory approvals for psilocybin-based products in Jamaica and other jurisdictions.
- Expansion of wellness retreat offerings and increased customer bookings.
- Development and commercialization of new functional mushroom products.
- Strategic partnerships with research institutions and healthcare providers.
- Increased public awareness and acceptance of psychedelics for therapeutic purposes.
What Are the Key Risks for SILFF?
Changing regulatory landscape for psychedelics.
- Competition from larger and more established companies.
- Negative public perception of psychedelics.
- Adverse side effects from psychedelic treatments.
- Limited operating history and financial resources.
What Are the Growth Opportunities for SILFF?
- Expansion of Wellness Retreats: Silo Wellness can expand its wellness retreat offerings in Jamaica and Oregon to attract a broader customer base. The global wellness tourism market is projected to reach $1.2 trillion by 2027, offering a significant opportunity for Silo Wellness to increase its revenue. By offering unique and immersive psychedelic wellness experiences, the company can differentiate itself from competitors and capture a larger share of the market. Timeline: Ongoing.
- Development and Commercialization of Psilocybin Nasal Spray: The development and commercialization of its psilocybin nasal spray in Jamaica represents a significant growth opportunity for Silo Wellness. The global market for psychedelic drugs is projected to reach $10.75 billion by 2027. A successful product launch could generate substantial revenue and establish Silo Wellness as a leader in the psychedelic medicine space. Timeline: 1-2 years.
- Cultivation and Sale of Psychedelic Mushrooms and Truffles: Silo Wellness's cultivation of psychedelic mushrooms and truffles in Jamaica provides a vertically integrated supply chain and a potential revenue stream. By expanding its cultivation capacity and developing new mushroom-based products, the company can capitalize on this growing market. Timeline: Ongoing.
- Establishment of Brick-and-Mortar Smart Shops: The development of brick-and-mortar smart shops in Jamaica offers Silo Wellness a direct-to-consumer channel for its products. The global retail market for wellness products is estimated at $1.5 trillion. By creating a unique and engaging retail experience, the company can attract customers and increase brand awareness. Timeline: 1 year.
- Strategic Partnerships and Acquisitions: Silo Wellness can pursue strategic partnerships and acquisitions to expand its product portfolio, geographic reach, and market share. Collaborating with other companies in the psychedelic wellness space can accelerate growth and create synergies. Identifying and acquiring complementary businesses can provide access to new technologies, markets, and customer segments. Timeline: Ongoing.
What Opportunities Does SILFF Have?
- Expansion of wellness retreat offerings to new locations.
- Development of new psychedelic-based therapies and products.
- Strategic partnerships with research institutions and healthcare providers.
- Increased public awareness and acceptance of psychedelics for therapeutic purposes.
What Are SILFF's Competitive Advantages?
- First-mover advantage in the emerging psychedelic wellness market.
- Vertically integrated supply chain for psychedelic mushrooms and truffles.
- Unique wellness retreat offerings in Jamaica and Oregon.
- Proprietary formulation of psilocybin nasal spray.
- Strategic partnerships with local communities and stakeholders in Jamaica.
What Does SILFF Do?
Silo Wellness Inc., formerly known as Yukoterre Resources Inc., was rebranded in February 2021 to reflect its strategic shift towards the psychedelics and wellness sector. The company is dedicated to developing psychedelic medicine aimed at reducing trauma and improving overall well-being. Silo Wellness operates in the emerging market of psychedelic wellness, offering a range of products and services. These include psilocybin-free functional mushroom tinctures, the formulation of a psilocybin nasal spray in Jamaica, Jamaican and Oregon psychedelic wellness retreats, and the cultivation of psychedelic mushrooms and truffles in Jamaica. The company is also developing brick-and-mortar smart shops in Jamaica to enhance accessibility to its products. Silo Wellness is headquartered in Toronto, Canada, and is strategically positioning itself to capitalize on the growing interest in psychedelic-assisted therapies and functional mushroom products. The company's diversified approach, encompassing product development, retreat offerings, and retail presence, aims to establish a comprehensive ecosystem within the psychedelic wellness market.
What Products and Services Does SILFF Offer?
- Develops psychedelic medicine to reduce trauma.
- Sells psilocybin-free functional mushroom tinctures.
- Formulates a psilocybin nasal spray in Jamaica.
- Offers Jamaican and Oregon psychedelic wellness retreats.
- Cultivates psychedelic mushrooms and truffles in Jamaica.
- Develops brick and mortar smart shops in Jamaica.
How Does SILFF Make Money?
- Direct sales of functional mushroom tinctures.
- Revenue from psychedelic wellness retreats.
- Potential future revenue from psilocybin nasal spray sales (subject to regulatory approval).
- Sales of cultivated psychedelic mushrooms and truffles.
- Retail sales through brick-and-mortar smart shops.
What Industry Does SILFF Operate In?
Silo Wellness Inc. operates within the rapidly evolving psychedelic wellness industry. This sector is experiencing significant growth due to increasing acceptance of psychedelics for therapeutic purposes and the growing demand for alternative wellness solutions. The market is characterized by a mix of established pharmaceutical companies, emerging biotech firms, and wellness startups. Competitors include companies focused on psychedelic drug development, retreat operators, and functional mushroom product manufacturers. The industry faces regulatory challenges and requires significant investment in research and development. As the market matures, companies that can demonstrate clinical efficacy and navigate the regulatory landscape will be best positioned for success.
Who Are SILFF's Key Customers?
- Individuals seeking alternative wellness solutions.
- People interested in psychedelic-assisted therapies.
- Tourists visiting Jamaica and Oregon seeking unique wellness experiences.
- Consumers of functional mushroom products.
- Patients seeking treatment for trauma and mental health conditions.
Company Profile
Silo Wellness Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Toronto, CA. The company is led by CEO Mike Arnold. SILFF has traded publicly since 2021.
How Silo Wellness Inc. Is Valued
Silo Wellness Inc. carries a market capitalization of $1.73M, placing it in the micro-cap category.
Key Financial Metrics
Return on equity for Silo Wellness Inc. stands at 205.3%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -47.4%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.01 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
Silo Wellness Inc.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile.
SILFF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Silo Wellness has been gaining traction in the wellness sector, leveraging the growing acceptance of psychedelics for mental health treatments.
- Recent insider buying suggests confidence in the company's future, indicating that key stakeholders believe in its potential.
- Community sentiment has shifted positively, with increased discussions around the benefits of Silo's products on social media platforms.
- New partnerships in the wellness industry have been announced, enhancing Silo's market presence and credibility.
Bear Case
- Regulatory uncertainties surrounding the psychedelic space continue to pose challenges, creating a cautious atmosphere among investors.
- Negative sentiment from some community members regarding the company's ability to scale its operations effectively adds to bearish outlooks.
- Recent market developments have led to skepticism about the sustainability of the current interest in wellness products, impacting Silo's perceived value.
- Competition in the psychedelics market is intensifying, raising concerns about Silo's ability to differentiate itself and maintain market share.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
SILFF Latest News
No recent news available for SILFF.
SILFF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SILFF.
Price Targets
Wall Street price target analysis for SILFF.
SILFF MoonshotScore
What does this score mean?
The MoonshotScore rates SILFF 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Mike Arnold
CEO
Mike Arnold serves as the CEO of Silo Wellness Inc. His background includes experience in the cannabis and wellness industries, with a focus on business development and strategic partnerships. He has a track record of building and scaling companies in emerging markets. Arnold's expertise in navigating regulatory landscapes and securing funding has been instrumental in driving Silo Wellness's growth. He holds a degree in Business Administration from a leading university.
Track Record: Under Mike Arnold's leadership, Silo Wellness has successfully expanded its wellness retreat offerings, secured key partnerships in Jamaica, and advanced the development of its psilocybin nasal spray. He has also overseen the company's rebranding and strategic shift towards the psychedelic wellness sector. Arnold's focus on innovation and market expansion has positioned Silo Wellness as a key player in the emerging psychedelic wellness industry.
SILFF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Silo Wellness Inc. may not meet the minimum financial or disclosure requirements for higher tiers like OTCQB or OTCQX. Companies in this tier are often early-stage, smaller, or have limited trading volume. Investing in OTC Other stocks carries significant risks due to the lack of regulatory oversight and potential for price manipulation. Investors should exercise extreme caution and conduct thorough due diligence before investing in SILFF.
- OTC Tier: OTC Other
- Limited regulatory oversight and disclosure requirements.
- Potential for price manipulation and fraud.
- Low trading volume and liquidity.
- Higher risk of financial distress or bankruptcy.
- Limited access to capital and funding.
- Verify the company's registration and legal status.
- Review the company's financial statements and disclosures (if available).
- Assess the company's management team and track record.
- Research the company's industry and competitive landscape.
- Evaluate the company's business model and growth prospects.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Company's focus on developing psychedelic medicine to reduce trauma.
- Wellness retreat offerings in Jamaica and Oregon.
- Cultivation of psychedelic mushrooms and truffles in Jamaica.
- Development of a psilocybin nasal spray.
- Presence of a CEO with experience in the wellness industry.
Common Questions About SILFF (Healthcare)
What does Silo Wellness Inc. do?
Silo Wellness Inc. is a psychedelics and wellness company focused on developing psychedelic medicine to reduce trauma. The company operates in the emerging market of psychedelic wellness, offering functional mushroom products, Jamaican and Oregon psychedelic wellness retreats, and exploring psilocybin-based treatments. It cultivates psychedelic mushrooms and truffles in Jamaica and aims to establish brick-and-mortar smart shops.
What do analysts say about SILFF stock?
As of March 17, 2026, there is no available analyst coverage for SILFF stock. Given its OTC listing and small market capitalization, the company may not be widely followed by analysts. Investors should conduct their own independent research and due diligence before investing in SILFF. Key valuation metrics to consider include the company's revenue growth, gross margin, and cash flow.
What are the main risks for SILFF?
Silo Wellness Inc. faces several risks, including regulatory uncertainty surrounding psychedelics, competition from larger and more established companies, and potential negative public perception of psychedelics. The company's limited operating history and financial resources also pose significant risks.
What are the key factors to evaluate for SILFF?
Evaluate SILFF on fundamentals, analyst consensus, and risk factors. Silo Wellness Inc. operates in the high-growth potential psychedelic wellness market. Not financial advice.
How frequently does SILFF data refresh on this page?
SILFF's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven SILFF's recent stock price performance?
Silo Wellness Inc. (SILFF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: First-mover advantage in the emerging psychedelic wellness market. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider SILFF overvalued or undervalued right now?
Silo Wellness Inc. (SILFF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research SILFF before investing?
Before investing in Silo Wellness Inc. (SILFF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- OTC market data may be limited and less reliable than exchange-listed data.
- Psychedelic wellness market is an emerging and rapidly evolving industry.